Susquehanna Maintains Neutral on Knowles, Raises Price Target to $40
Susquehanna analyst Christopher Rolland maintains Knowles (NYSE:KN) with a Neutral and raises the price target from $33 to $40.
Read original at benzingaStocks · News reference
Knowles Announces Agreement To Manufacture Elucent Medical's Smart Surgical Guidance Device For EnVisio System At Penang, Malaysia Facility
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 12, 2026, 12:06 PM
- Checked
- Aug 12, 2026, 12:06 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Full Transcript: Knowles Q2 2026 Earnings Call
On Thursday, Knowles (NYSE:KN) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This transcript is brought to you by Benzinga APIs. For real-time access to our
Read original at benzingaKnowles Sees Q3 GAAP EPS $0.22-$0.26 vs $0.23 Est
Knowles (NYSE:KN) is looking for Q3 GAAP EPS of $0.22-$0.26 vs $0.23 analyst estimate..
Read original at benzinga